Innovation
Council
Leading biomedical innovators support No Patient Left Behind's mission.
NPLB is guided by its councils of accomplished and passionate individuals including patient advocates, physicians, innovators, investors, payors, and health economists.
These councils support NPLB's efforts to bring about reforms that make today's treatments affordable to the people who need them and ensure that we can look forward to better ones tomorrow.
Innovation Council Members
Amanda Banks
Company Builder, Advisor, Physician
Tess Cameron
Principal
RA Capital Management
Michael Chen
Co-founder & Chief Scientific Officer
Seaport Therapeutics.
Grace Colón
Biotech Executive, CEO, Board Member and Entrepreneur
Paul Hastings
Chief Executive Officer
Nkarta Therapeutics
Paul Kim
Life Science and Health Policy Advisor, FDA Lawyer
Jeremy Levin
Chief Executive Officer and Chairman
Ovid Therapeutics
John Maraganore
CEO and Principal
JMM Innovations
Ali Urman
Investor
ARK Invest
Melanie Whittington
Head, Leerink Center for Pharmacoeconomics, MEDACorp
Richard Xie
Senior Economic and Policy Advisor
RA Capital Management
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.